Hot Features
Premium
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Período:
Tipo de Línea:
| Volume | 116,573 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Alzamend Neuro Inc | ALZN | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.0105 | 2.63% | 0.4095 | 18:30:29 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.4189 | 0.398 | 0.4299 | 0.399 | 0.399 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
|---|---|---|---|---|
| 396 | 116,573 | US$ 0.4099468 | US$ 47,789 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 18:23:10 | formt | 113 | US$ 0.4095 | USD |
Información Financiera Alzamend Neuro Inc ALZN
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 2.85M | 7.12M | - | 0 | -14.88M | -2.09 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Alzamend Neuro Inc ALZN
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 11/6/2024 | 15:30 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 03/6/2024 | 15:30 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 31/5/2024 | 15:59 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 22/5/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/5/2024 | 07:00 | Business Wire | Alzamend Neuro Announces Favorable Decision from Nasdaq.. |
| 16/5/2024 | 15:30 | Edgar (US Regulatory) | Form 5 - Annual statement of changes in beneficial ownership.. |
| 14/5/2024 | 07:00 | Business Wire | Alzamend Neuro Announces Initial Closing of Private.. |
| 13/5/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/5/2024 | 16:06 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 10/5/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 10/5/2024 | 05:30 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 09/5/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos ALZN
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
